Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Squamous Intraepithelial Lesions 1Muscle Invasive Bladder Cancer (MIBC) 1Limited Stage Small Cell Lung Cancer 1Helicobacter Infections 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Carcinoma In Situ 1Anus Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

durvalumab 2Etoposide 2Cisplatin 2tislelizumab 1pamiparib 1anlotinib 1Tirapazamine 1Radiotherapy 1Radiation Dose Hypofractionation 1Radiation 1Probiotics 1Immunotherapy 1Drug Therapy 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Limited Stage Small Cell Lung Cancer × Probiotics × Clear all
NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

Fudan University

Phase 2 Recruiting
60 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡